Parabilis takes top spot, pricing largest biopharma IPO at $670M

IlluminaIllumina upgraded to overweight at JPMorgan on clinical demand outlook - Investing.com

Endpoints NewsRare disease biotech Beren adds $300M from new financings

Clinical OMICsAI Tool Classifies 102 CNS Tumor Subtypes in Minutes

Clinical OMICsFast-Acting Malaria Drug Shows Promise in First-in-Human Study

Clinical OMICsUltrasensitive HPV DNA Blood Test Could Help Personalize Head and Neck Cancer Treatment

Clinical OMICsDigital Portal Strengthens Patient Engagement in Cancer Clinical Trials

Clinical OMICsAI Detects Breast Cancer Much Earlier than Radiologists Alone

FierceBiotechFrom executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industry

Endpoints NewsParabilis CEO Mathai Mammen on biotech's record IPO

IlluminaCalls of the day: Illumina, Netflix and REITs - MSN

Promega BlogPromega Builds Opportunity to Appreciate Hidden Wetland